Table 3. Comparison of the clinical characteristics between IC/BPS patients with a higher and lower of median serum NGF levels.
Lower serum NGF (n = 15) | Higher serum NGF (n = 15) | P value | |
Age | 45.4±9.50 | 58.7±20.8 | 0.102 |
O’Leary-Sant Score | 24.1±3.50 | 23.3±4.03 | 0.650 |
VAS pain score | 5.0±2.42 | 4.11±2.32 | 0.398 |
Cystometric capacity | 200±84.8 | 292±105 | 0.035 |
Qmax | 11.3±5.32 | 13.3±5.92 | 0.401 |
PVR | 20.4±40.5 | 62.2±54.3 | 0.051 |
Functional capacity | 142±81.7 | 125±96.2 | 0.665 |
Frequency | 12.7±3.59 | 11.3±2.87 | 0.357 |
Nocturia | 4.08±1.55 | 3.11±1.54 | 0.165 |
Maximal bladder capacity | 577±128 | 617±189 | 0.562 |
Glomerulation degree | 2.08±0.75 | 1.78±0.83 | 0.392 |
Ulcer type case | 1 | 0 | |
Serum NGF | 2.07±1.18 | 4.13±1.02 | <0.0001 |
Qmax: maximum flow rate, VAS: visual analog score, PVR: postvoid residual, NGF: nerve growth factor.